Literature DB >> 15564236

FDA is incapable of protecting US "against another Vioxx".

Jeanne Lenzer.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15564236      PMCID： PMC534432          DOI： 10.1136/bmj.329.7477.1253

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  18 in total

1.  Europe also needs agency for postmarketing surveillance.

Authors:  Silvio Garattini
Journal:  BMJ       Date:  2005-03-05

2.  Drug safety and regulation.

Authors:  Patrick C Waller; Stephen J W Evans; Keith Beard
Journal:  BMJ       Date:  2005-07-02

Review 3.  Direct-to-consumer advertising of pharmaceuticals: developed countries experiences and Turkey.

Authors:  Semih Semin; Sahbal Aras; Dilek Guldal
Journal:  Health Expect       Date:  2007-03       Impact factor: 3.377

Review 4.  Today's challenges in pharmacovigilance: what can we learn from epoetins?

Authors:  Hans C Ebbers; Aukje K Mantel-Teeuwisse; Ellen H M Moors; Huub Schellekens; Hubert G Leufkens
Journal:  Drug Saf       Date:  2011-04-01       Impact factor: 5.606

5.  How the continuity of care document can advance medical research and public health.

Authors:  John D D'Amore; Dean F Sittig; Roberta B Ness
Journal:  Am J Public Health       Date:  2012-03-15       Impact factor: 9.308

Review 6.  Data-driven methods to discover molecular determinants of serious adverse drug events.

Authors:  A P Chiang; A J Butte
Journal:  Clin Pharmacol Ther       Date:  2009-01-28       Impact factor: 6.875

7.  QT interval prolongation associated with sibutramine treatment.

Authors:  Mira Harrison-Woolrych; David W J Clark; Geraldine R Hill; Mark I Rees; Jonathan R Skinner
Journal:  Br J Clin Pharmacol       Date:  2006-04       Impact factor: 4.335

Review 8.  Pharmacovigilance: methods, recent developments and future perspectives.

Authors:  L Härmark; A C van Grootheest
Journal:  Eur J Clin Pharmacol       Date:  2008-06-04       Impact factor: 2.953

9.  Drug safety information through the internet: the experience of an Italian website.

Authors:  Giovanni Polimeni; Alessandra Russo; Maria Antonietta Catania; Andrea Aiello; Alessandro Oteri; Gianluca Trifirò; Gioacchino Calapai; Lidia Sautebin; Massimo Iacobelli; Achille P Caputi
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

10.  Influence of regulatory measures on the rate of spontaneous adverse drug reaction reporting in Italy.

Authors:  Domenico Motola; Antonio Vargiu; Roberto Leone; Anita Conforti; Ugo Moretti; Alberto Vaccheri; Giampaolo Velo; Nicola Montanaro
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.